Re: Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas

Samir S. Taneja

doi:10.1016/j.juro.2011.10.116

Re: Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	Journal of Urology
Volume	187
Issue number	2
DOIs	https://doi.org/10.1016/j.juro.2011.10.116
State	Published - Feb 2012

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2011.10.116

Cite this

@article{8672dc8e8a7d4954b6b45c90b9c96e37,

title = "Re: Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas",

author = "Taneja, {Samir S.}",

year = "2012",

month = feb,

doi = "10.1016/j.juro.2011.10.116",

language = "English (US)",

volume = "187",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Re

T2 - Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas

AU - Taneja, Samir S.

PY - 2012/2

Y1 - 2012/2

UR - http://www.scopus.com/inward/record.url?scp=84855601445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855601445&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2011.10.116

DO - 10.1016/j.juro.2011.10.116

M3 - Comment/debate

C2 - 22237313

AN - SCOPUS:84855601445

SN - 0022-5347

VL - 187

JO - Journal of Urology

JF - Journal of Urology

IS - 2

ER -

Re: Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this